loading page

Biotechnological approaches to the production of promising plant-derived anticancer agents: An update and overview
  • +9
  • Li Changxing,
  • Saddia Galani,
  • Zubia Rashid,
  • Faiz-ul Hassan,
  • Muhammad Naveed,
  • Daidong Fang,
  • Asma Ashraf,
  • Wang Qi,
  • Afsheen Arif,
  • Muhammad Saeed,
  • Arif Ali Chishti,
  • Li Jianhua
Li Changxing
Saddia Galani
Zubia Rashid
Faiz-ul Hassan
Muhammad Naveed
Nanjing Medical University

Corresponding Author:[email protected]

Author Profile
Daidong Fang
Asma Ashraf
Afsheen Arif
Muhammad Saeed
Author Profile
Arif Ali Chishti
Li Jianhua


The plant kingdom is a rich source of bioactive compounds, many of which have used since pre-history for their therapeutic properties to treat a range of illnesses. More recently, some of these metabolites have attracted attention to their antineoplastic activities to treat various cancers relying on different mechanisms to kill. Some of these molecules are glycosides, which have proven useful as anti-cancer agents, namely podophyllotoxin (PPT) anaryltetralin lignan or alkaloids. There are three primary forms of alkaloids, such as indole alkaloids (vincristine and vinblastine from Catharanthus roseus) quinoline alkaloid (camptothecin from Camptotheca acuminata) and diterpenoid alkaloid (taxol and it’s analogous from Taxus and Corylus species). This review considers a variety of plant biotechnology approaches used to enhance the production of these anticancer molecules in different species. In this regard, many in vitro culture techniques such as stimulation of suspension culture and hairy roots are being used to investigate the effects of plant growth regulators and elicitors on various explants.